{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:05Z","timestamp":1761919745880},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T00:00:00Z","timestamp":1381536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00415-013-7128-3","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T17:46:05Z","timestamp":1381513565000},"page":"3150-3157","source":"Crossref","is-referenced-by-count":14,"title":["Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder"],"prefix":"10.1007","volume":"260","author":[{"given":"Youming","family":"long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangbo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,12]]},"reference":[{"issue":"5","key":"7128_CR1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1191\/1352458503ms947oa","volume":"9","author":"J Seze de","year":"2003","unstructured":"de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P (2003) Is Devic\u2019s neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 9(5):521\u2013525","journal-title":"Mult Scler"},{"issue":"10","key":"7128_CR2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489","journal-title":"Neurology"},{"issue":"1","key":"7128_CR3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock SJ, Lennon VA, de Seze J et al (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78\u201383","journal-title":"Arch Neurol"},{"issue":"9451","key":"7128_CR4","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112","journal-title":"Lancet"},{"issue":"1","key":"7128_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","volume":"79","author":"MJ Cuadrado","year":"2000","unstructured":"Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR (2000) Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 79(1):57\u201368","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl","key":"7128_CR6","first-page":"28","volume":"117","author":"A Czlonkowska","year":"2007","unstructured":"Czlonkowska A, Sliwinska A (2007) Multiple sclerosis and antiphospholipid syndrome\u2014difficulties in differential diagnostics. Pol Arch Med Wewn 117(Suppl):28\u201332","journal-title":"Pol Arch Med Wewn"},{"issue":"3","key":"7128_CR7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3899\/jrheum.120084","volume":"40","author":"E Akhter","year":"2013","unstructured":"Akhter E, Shums Z, Norman GL, Binder W, Fang H, Petri M (2013) Utility of antiphosphatidylserine\/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus. J Rheumatol 40(3):282\u2013286","journal-title":"J Rheumatol"},{"issue":"5","key":"7128_CR8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00296-001-0157-8","volume":"21","author":"EM El-Ageb","year":"2002","unstructured":"El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER (2002) Clinical features of Behcet\u2019s disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies. Rheumatol Int 21(5):176\u2013181","journal-title":"Rheumatol Int"},{"issue":"2","key":"7128_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/096120399678847461","volume":"8","author":"JW IJdo","year":"1999","unstructured":"IJdo JW, Conti-Kelly AM, Greco P et al (1999) Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS. Lupus 8(2):109\u2013115","journal-title":"Lupus"},{"key":"7128_CR10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2377-7-36","volume":"7","author":"CJ Bidot","year":"2007","unstructured":"Bidot CJ, Horstman LL, Jy W et al (2007) Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol 7:36","journal-title":"BMC Neurol"},{"issue":"3","key":"7128_CR11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-0404.1993.tb04214.x","volume":"88","author":"T Fukazawa","year":"1993","unstructured":"Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K (1993) Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 88(3):184\u2013189","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"7128_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1620\/tjem.178.203","volume":"178","author":"Y Sugiyama","year":"1996","unstructured":"Sugiyama Y, Yamamoto T (1996) Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis. Tohoku J Exp Med 178(3):203\u2013215","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"7128_CR13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.410440408","volume":"44","author":"D Karussis","year":"1998","unstructured":"Karussis D, Leker RR, Ashkenazi A, Abramsky O (1998) A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity. Ann Neurol 44(4):629\u2013634","journal-title":"Ann Neurol"},{"issue":"4","key":"7128_CR14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0961203311427550","volume":"21","author":"M Szmyrka-Kaczmarek","year":"2012","unstructured":"Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B et al (2012) Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus 21(4):412\u2013420","journal-title":"Lupus"},{"issue":"9","key":"7128_CR15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0248-8663(99)80042-3","volume":"19","author":"MA Cordoliani","year":"1998","unstructured":"Cordoliani MA, Michon-Pasturel U, Rerat K et al (1998) Multiple sclerosis and antiphospholipid antibodies: study of 62 consecutive patients. Rev Med Interne 19(9):635\u2013639","journal-title":"Rev Med Interne"},{"issue":"2","key":"7128_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0213-4853(10)70029-3","volume":"25","author":"P Carrillo-Mora","year":"2010","unstructured":"Carrillo-Mora P, Gonzalez-Villalva A (2010) Clinical characteristics and presence of antiphospholipid antibodies (anticardiolipin-beta2GP-1) cerebrospinal fluid and serum of in a series of patients with multiple sclerosis in Mexico. Neurologia 25(2):71\u201377","journal-title":"Neurologia"},{"issue":"5","key":"7128_CR17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1212\/WNL.51.5.1376","volume":"51","author":"L D\u2019Olhaberriague","year":"1998","unstructured":"D\u2019Olhaberriague L, Levine SR, Salowich-Palm L et al (1998) Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases. Neurology 51(5):1376\u20131380","journal-title":"Neurology"},{"issue":"9","key":"7128_CR18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815","journal-title":"Lancet Neurol"},{"issue":"24","key":"7128_CR19","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1212\/WNL.0b013e318296ea08","volume":"80","author":"DK Sato","year":"2013","unstructured":"Sato DK, Nakashima I, Takahashi T et al (2013) Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 80(24):2210\u20132216","journal-title":"Neurology"},{"issue":"2","key":"7128_CR20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"11","key":"7128_CR21","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"8","key":"7128_CR22","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/JCM.34.8.2011-2013.1996","volume":"34","author":"Q Huang","year":"1996","unstructured":"Huang Q, Lan X, Tong T et al (1996) Dot-immunogold filtration assay as a screening test for syphilis. J Clin Microbiol 34(8):2011\u20132013","journal-title":"J Clin Microbiol"},{"issue":"2","key":"7128_CR23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000330240","volume":"19","author":"Y Long","year":"2012","unstructured":"Long Y, Qiu W, Lu Z et al (2012) Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica. Neuroimmunomodulation 19(2):96\u2013102","journal-title":"Neuroimmunomodulation"},{"issue":"9","key":"7128_CR24","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","volume":"69","author":"MA Mealy","year":"2012","unstructured":"Mealy MA, Wingerchuk DM, Greenberg BM, Levy M (2012) Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol 69(9):1176\u20131180","journal-title":"Arch Neurol"},{"issue":"5","key":"7128_CR25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jnnp.72.5.647","volume":"72","author":"O Heinzlef","year":"2002","unstructured":"Heinzlef O, Weill B, Johanet C et al (2002) Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry 72(5):647\u2013649","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"7128_CR26","first-page":"639","volume":"32","author":"H Ito","year":"1992","unstructured":"Ito H, Nagasato K, Nakamura T, Tsujihata M, Nagataki S (1992) Transverse myelopathy in a patient with systemic lupus erythematosus associated with positive anticardiolipin antibody\u2014a case report. Rinsho Shinkeigaku 32(6):639\u2013641","journal-title":"Rinsho Shinkeigaku"},{"issue":"2","key":"7128_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/135245859900500209","volume":"5","author":"M Spadaro","year":"1999","unstructured":"Spadaro M, Amendolea MA, Mazzucconi MG et al (1999) Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler 5(2):121\u2013125","journal-title":"Mult Scler"},{"issue":"1","key":"7128_CR28","first-page":"34","volume":"17","author":"C Lavalle","year":"1990","unstructured":"Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D (1990) Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 17(1):34\u201337","journal-title":"J Rheumatol"},{"issue":"2","key":"7128_CR29","first-page":"280","volume":"31","author":"DP D\u2019Cruz","year":"2004","unstructured":"D\u2019Cruz DP, Mellor-Pita S, Joven B et al (2004) Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 31(2):280\u2013285","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"7128_CR30","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s10875-012-9796-7","volume":"33","author":"DM Wingerchuk","year":"2013","unstructured":"Wingerchuk DM (2013) Neuromyelitis optica: potential roles for intravenous immunoglobulin. J Clin Immunol 33(Suppl 1):S33\u2013S37","journal-title":"J Clin Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7128-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7128-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7128-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T19:15:04Z","timestamp":1596654904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7128-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["7128"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7128-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,12]]}}}